Table III.
Correlation between the expression of VEGF and its recepteors with MVD in ovarian cancer.
| MVD
|
|||||
|---|---|---|---|---|---|
| Protein | Expression | Cases, n | Mean | Range | Kruskal-Wallis P-value |
| VEGF | Positive | 32 | 19.51±8.69 | 7.2–46.0 | |
| Negative | 16 | 12.68±4.04 | 4.1–21.6 | 0.01 | |
| KDR | Positive | 21 | 21.64±8.63 | 10.2–46.0 | |
| Negative | 27 | 17.06±7.87 | 4.1–37.8 | 0.03 | |
| Flt-1 | Positive | 28 | 19.19±9.53 | 4.1–46.0 | |
| Negative | 20 | 17.16±6.74 | 8.2–29.4 | 0.54 | |
VEGF, vascular endothelial growth factor; MVD, microvessel density.